MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number 37612 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Inflammation (1932)
|
Event Date 02/01/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: other relevant device(s) are: product id: neu_unknown_lead, product id: neu_unknown_ext.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that there was inflammatory signs around the implantable neurostimulator (ins) pocket area.The patient was diagnosed with subcutaneous infection of deep brain stimulation (dbs) device components, resulting in hospitalization.Medications were administered on (b)(6) 2022.The extension was explanted on (b)(6) 2022 and the lead was explanted on (b)(6) 2022.The issue is ongoing.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 3391-40, lot# 0215156970, implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type lead product id 3708695, serial# (b)(6), implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type extension ins could be (b)(6) with implant date of (b)(6), 2020.Extension could be (b)(6) lead could be 0215156971 follow up is being conducted to further clarify.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 3708695, serial# (b)(6), implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type extension product id 3391-40, lot# 0215156971, implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type lead product id 3391-40, lot# 0 215156970, implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type lead product id 3708695, serial# (b)(6), implanted: (b)(6) 2019, explanted: (b)(6) 2022, product type extension g9- the manufacturing site id was previously reported as 2182207.Additional review indicates the correct manufacturing site id is (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the health care provider (hcp) of a clinical study reporting that the ins was explanted on (b)(6) 2022, both extensions explanted on (b)(6) 2022, and both leads explanted on (b)(6) 2022 due to the infection.
|
|
Event Description
|
Additional information was received: it was reported that the issue resolved without sequelae on (b)(6)2022.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 3708695 lot# serial# (b)(6) implanted: (b)(6)2019 explanted: (b)(6)2022 product type extension product id 3391-40 lot# 0215156971 implanted: (b)(6)2019 explanted: (b)(6)2022 product type lead product id 3391-40 lot# 0 215156970 implanted: (b)(6)2019 explanted: (b)(6)2022 product type lead product id 3708695 lot# serial# (b)(6) implanted: (b)(6)2019 explanted: (b)(6)2022 product type extension medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|